Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Rxsight Inc RXST

RxSight, Inc. is a commercial-stage medical technology company, which is engaged in improving the vision of patients following cataract surgery. The Company’s RxSight Light Adjustable Lens system (RxSight system) is a cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system includes the RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and various accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. It designed its RxSight system to address the shortcomings of competitive IOL technologies and provide a solution that doctors can trust to improve visual outcomes. Its RxSight system helps the surgeon perform a standard cataract procedure to implant the LAL and then uses the LDD to modify the lens with the visual correction needed for the patient’s vision outcomes.


NDAQ:RXST - Post by User

Bullboard Posts
Next >>
Post by AviseAnalyticson Jul 10, 2023 8:39am
76 Views
Post# 35533297

RXSIGHT: ENVISIONING A BRIGHT FUTURE

RXSIGHT: ENVISIONING A BRIGHT FUTURE
$RXST

Excited to share an article about RxSight, Inc. (NASDAQ: RXST), an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery.

RxSight’s first-in-class light adjustable lens (LAL) consistently delivers unparalleled visual results. Additionally, the growth of LAL premium pay procedures is aligned with the economic success of doctors and practices - this has led to an astounding financial performance by the Company over the last few quarters.

Read on to know more:

https://www.aviseanalytics.com/rxsight-envisioning-a-bright-future/

 


Bullboard Posts
Next >>